Molecular Cancer Research

Tumor Microenvironment Immunosuppressive Cell Dynamics

Investigates mechanisms by which cancer-associated fibroblasts, myeloid-derived suppressor cells, and regulatory T cells create immunosuppressive niches that promote tumor growth and metastasis.

RESEARCH GAP FRONTIERS

Liquid Biopsy Circulating Tumor DNA Detection

Develops and optimizes non-invasive blood-based diagnostic methods to detect, quantify, and characterize circulating tumor DNA for early cancer detection and treatment monitoring.

RESEARCH GAP FRONTIERS

Epigenetic Reprogramming in Cancer Stem Cells

Explores histone modifications, DNA methylation patterns, and chromatin remodeling that maintain cancer stem cell self-renewal and therapeutic resistance properties.

RESEARCH GAP FRONTIERS

CRISPR Base Editing for Oncogenic Driver Mutations

Develops precision base editing strategies to directly correct cancer-causing point mutations without generating double-strand breaks in tumor cells.

RESEARCH GAP FRONTIERS

Metabolic Reprogramming Warburg Effect Mechanisms

Analyzes how cancer cells rewire glucose and lipid metabolism pathways to support rapid proliferation and escape metabolic stress during tumorigenesis.

RESEARCH GAP FRONTIERS

Extracellular Vesicle-Mediated Tumor Communication

Studies how exosomes and microvesicles transfer oncogenic cargo between cancer cells and promote intercellular signaling within the tumor ecosystem.

RESEARCH GAP FRONTIERS

Immunotherapy Resistance Checkpoint Blockade Escape

Investigates molecular mechanisms enabling tumors to evade anti-PD-1, anti-PD-L1, and anti-CTLA-4 immunotherapies through immune editing and intrinsic resistance pathways.

RESEARCH GAP FRONTIERS

Synthetic Lethality Precision Cancer Drug Discovery

Identifies genetic dependencies and vulnerability combinations in specific tumor types to develop targeted therapies with enhanced selectivity and reduced toxicity.

Cancer Metastasis Epithelial-Mesenchymal Transition

Characterizes transcriptional and post-translational regulation of EMT programs that enable cancer cell invasion, dissemination, and colonization of distant organs.

Tumor Heterogeneity Single-Cell Genomic Analysis

Uses single-cell RNA sequencing, multi-omics profiling, and spatial transcriptomics to map genomic and transcriptomic diversity within individual tumors.

Proteasome Inhibition Ubiquitin-Proteasome Pathway

Investigates how selective proteasome inhibitors disrupt protein quality control and induce apoptosis in multiple myeloma and solid tumor cells.

DNA Damage Response Repair Pathway Inhibition

Studies PARP inhibitors, ATR inhibitors, and CHK1/CHK2 modulators to exploit homologous recombination deficiency and enhance cancer cell lethality.

Hypoxia-Inducible Factor Signaling Tumor Adaptation

Examines HIF-1alpha and HIF-2alpha regulation of metabolic switching, angiogenesis, and immunosuppression in hypoxic tumor microenvironments.

Wnt Signaling Pathway Activation Colorectal Cancer

Analyzes APC mutations, beta-catenin stabilization, and TCF/LEF transcription factor activity driving intestinal adenoma formation and progression.

Targeted Protein Degradation Molecular Glue Compounds

Designs cereblon and VHL-recruiting molecules that induce selective degradation of undruggable cancer oncoproteins via proteasomal pathways.

Tumor Angiogenesis VEGF Signaling Inhibition

Studies anti-angiogenic mechanisms of VEGF receptor tyrosine kinase inhibitors and monoclonal antibodies to prevent tumor neovascularization.

Chromosomal Instability Segregation Error Mechanisms

Investigates how defects in mitotic checkpoint control, centrosome duplication, and kinetochore assembly generate chromosomal aberrations fueling cancer evolution.

CAR-T Cell Engineering Tumor Antigen Targeting

Develops chimeric antigen receptor designs, costimulatory domains, and safety switches to enhance T cell-mediated tumor killing while minimizing toxicity.

Long Non-Coding RNA Oncogenic Functions

Characterizes lncRNA mechanisms in competing endogenous RNA networks, chromatin remodeling, and transcriptional regulation of cancer-associated genes.

MicroRNA-Mediated Gene Silencing Cancer Networks

Analyzes microRNA dysregulation, seed-region targeting specificity, and functional roles in tumor suppression and oncogenic transformation.

Mutational Signature Analysis Carcinogen Identification

Deciphers DNA mutation patterns to identify causative carcinogens, mutational processes, and potential therapeutic vulnerabilities in cancer genomes.

Clonal Evolution Tumor Phylogenetic Reconstruction

Reconstructs evolutionary histories of cancer clones using multi-region sequencing and computational phylogenetics to understand treatment resistance development.

TP53 Mutation Consequences Tumor Suppression Loss

Investigates how TP53 inactivation ablates DNA damage checkpoints, apoptosis, and other tumor suppressive functions across cancer types.

RAS-MAPK Pathway Hyperactivation Signaling Dependencies

Studies KRAS, NRAS, and HRAS mutations and downstream MEK/ERK signaling as drivers of pancreatic, lung, and melanoma cancers.

PI3K-AKT-mTOR Axis Survival Signal Integration

Analyzes phosphatidylinositol 3-kinase signaling cascade controlling protein synthesis, cell survival, and metabolism in PTEN-deficient tumors.

Programmed Death Ligand Expression Immune Evasion

Investigates regulatory mechanisms controlling PD-L1 surface expression and soluble PD-L1 shedding enabling tumor immune checkpoint engagement.

Therapy-Induced Senescence Cancer Cell Dormancy

Examines senescent phenotypes induced by chemotherapy, radiation, and targeted drugs including secretory factors promoting tumor relapse.

Tumor-Associated Macrophage Polarization M1 M2

Studies macrophage phenotypic switching from anti-tumor M1 to pro-tumoral M2 states and therapeutic targeting of tumor-promoting functions.

Neutrophil Extracellular Trap Formation Cancer Biology

Analyzes NET-mediated mechanisms supporting tumor progression, metastasis, and immunosuppression within the cancer microenvironment.

Dormant Micrometastasis Reactivation Recurrence Mechanisms

Investigates how disseminated cancer cells remain quiescent in distant tissues and what signals trigger their exit from dormancy and overt metastatic outgrowth.

Bone Marrow Niche Tumor Cell Homing

Studies molecular mechanisms of cancer cell lodgment in bone marrow osteogenic and vascular niches supporting leukemic and carcinoma cell survival.

Cancer Associated Fibroblast Activation CAF Phenotypes

Characterizes myofibroblast differentiation, ECM remodeling, and growth factor secretion by CAFs that promote tumor stroma formation and progression.

Tumor Vessel Normalization Anti-Angiogenic Timing

Investigates transient vascular normalization windows after anti-VEGF therapy that enhance chemotherapy and immunotherapy efficacy through improved perfusion.

Immune Checkpoint CD47 Thrombospondin Interactions

Studies CD47 -SIRPalpha ''don''t eat me'' signals enabling cancer cells to evade macrophage phagocytosis and therapeutic targeting approaches.

Histone Methyltransferase EZH2 Polycomb Repression

Examines H3K27 trimethylation mediated gene silencing by PRC2 complex and therapeutic vulnerabilities in EZH2-mutant lymphomas.

HDAC Inhibition Histone Acetylation Reactivation

Studies histone deacetylase inhibitors that promote open chromatin configuration and reactivate silenced tumor suppressor and differentiation genes.

Neuroendocrine Differentiation Small Cell Carcinoma

Investigates transcriptional programming driving neuroendocrine phenotypes, chromogranin expression, and aggressive behavior in small cell lung and prostate cancers.

Squamous Cell Differentiation TP63 Delta Isoforms

Analyzes TP63 isoform expression controlling squamous differentiation programs in head and neck, lung, and bladder cancers.

Tumor Dormancy Quiescence Exit Signal Transduction

Examines growth factor signaling, metabolic shifts, and microenvironmental cues triggering cancer cell dormancy exit and proliferative awakening.

Combinatorial Drug Synergy Screening Platform

Develops high-throughput methods to identify synergistic drug combinations overcoming single-agent resistance and improving therapeutic outcomes.

Organoid-Based Personalized Medicine Drug Testing

Uses patient-derived tumor organoids and tumoroids to predict chemotherapy and targeted therapy responses for precision oncology treatment planning.

MHC Class I Antigen Presentation Immunoescape

Studies cancer mutations in MHC genes, transporter associated with antigen processing, and proteasomal processing enabling immune escape from cytotoxic T cells.

Tumor-Intrinsic PD-L1 Expression Regulation Mechanisms

Investigates constitutive and interferon-gamma-inducible PD-L1 expression through STAT3, NF-kappa-B, and PI3K signaling in cancer cells.

Splice Variant Isoform Switching Cancer Function

Analyzes alternative splicing program alterations driven by SF3B1, SRSF proteins, and RNA-binding proteins that generate cancer-specific protein isoforms.

Aromatase Inhibitor Resistance Estrogen Receptor

Investigates mechanisms of endocrine therapy resistance in breast cancer including ESR1 mutations, altered coactivators, and kinase pathway activation.

Androgen Receptor Variant Expression Prostate Cancer

Studies constitutively active androgen receptor truncations, ligand-independent signaling, and therapy resistance in castration-resistant prostate cancer.

HER2 Heterogeneity Breast Cancer Subtyping

Analyzes HER2 amplification heterogeneity, HER2-low populations, and implications for targeted therapy eligibility and treatment efficacy.

Oncolytic Virus Engineering Immunogenic Cell Death

Develops replication-competent viral vectors engineered to selectively kill cancer cells while triggering immunogenic cell death and anti-tumor immunity.

Immunogenic Cell Death Danger-Associated Molecular Patterns

Investigates DAMPs release mechanisms from chemotherapy and radiation-treated tumors that activate dendritic cells and anti-tumor immune responses.

Tertiary Lymphoid Structure Formation Tumor Immunity

Studies ectopic lymph node development within tumors and associations with immunotherapy response, with implications for therapeutic optimization.

Ferroptosis Iron-Dependent Cell Death Pathways

Investigates iron metabolism and lipid peroxidation mechanisms driving ferroptotic cancer cell death as an alternative to apoptosis.

Autophagy Flux Modulation Therapeutic Targeting

Explores selective autophagy regulation and lysosomal degradation pathways for cancer cell elimination and tumor suppression.

Necroptosis RIPK Kinase Signaling Activation

Examines receptor-interacting serine/threonine-protein kinase-mediated programmed necrosis as immunogenic cancer cell death mechanism.

Pyroptosis Inflammasome Caspase-1 Activation

Investigates gasdermin-mediated pyroptotic pathways and inflammasome assembly for immunogenic tumor cell elimination.

Parthanatos PARP-Dependent Cell Death

Studies poly(ADP-ribose) polymerase overactivation and AIF-mediated parthanatic death in cancer therapeutics.

Cuproptosis Copper Metabolism Cancer Targeting

Examines copper-dependent protein aggregation and mitochondrial dysfunction as novel cancer cell death mechanism.

NAD Metabolism Sirtuin Signaling Cancer

Investigates nicotinamide adenine dinucleotide-dependent pathways and sirtuin deacetylases in tumor metabolic reprogramming.

Lipid Metabolism Fatty Acid Oxidation

Explores adipose tissue-derived fatty acid uptake and mitochondrial oxidation fueling cancer cell survival.

Glutamine Addiction mTORC1 Signaling

Analyzes glutaminolysis and mTORC1-mediated nutrient sensing pathways driving cancer cell proliferation.

One-Carbon Metabolism Methylation Dependency

Investigates serine, glycine, and folate metabolism supporting DNA methylation and cancer cell growth.

Arginine Metabolism Nitric Oxide Production

Studies arginine depletion and nitric oxide signaling in immunosuppressive tumor microenvironment regulation.

Tryptophan Metabolism Kynurenine Pathway

Examines indoleamine 2,3-dioxygenase-mediated tryptophan catabolism driving immune tolerance in cancer.

Cholesterol Synthesis SREBP Pathway Cancer

Investigates sterol regulatory element-binding protein-dependent lipogenesis supporting membrane biogenesis in cancer cells.

Nucleotide Synthesis De Novo Pathways

Analyzes ribose-5-phosphate pathway and nucleotide biosynthesis enzymes essential for DNA replication in cancer.

Lactate Metabolism Monocarboxylate Transporter

Explores lactate production and symbiotic lactate-fueled metabolism between cancer and immune cells.

Mitochondrial Dysfunction Cristae Organization

Studies OPA1-mediated cristae remodeling and mitochondrial dynamics regulating cancer cell metabolism and apoptosis.

Reactive Oxygen Species Antioxidant Defense

Investigates redox homeostasis, glutathione metabolism, and thioredoxin systems in cancer cell survival.

Fenton Chemistry Iron Catalysis DNA Damage

Examines iron-catalyzed reactive oxygen species generation and oxidative DNA damage in cancer therapy.

Protein Aggregation Amyloid Prion Cancer

Explores misfolded protein transmission and prion-like propagation mechanisms in cancer cell populations.

Phase Separation Biomolecular Condensates

Investigates liquid-liquid phase separation creating transcriptional hubs and oncogenic signaling compartments in cancer.

Chromatin Accessibility ATAC-Seq Profiling

Analyzes open chromatin landscapes and ATAC-seq dynamics revealing cancer cell-type-specific transcriptional programs.

Three-Dimensional Genome Architecture TAD Domains

Studies topologically associating domain reorganization and enhancer-promoter interactions driving cancer gene expression.

Super-Enhancer Driven Oncogene Activation

Investigates large transcriptional enhancers and BRD4 recruitment mechanisms amplifying oncogenic transcription.

Nucleosome Positioning Chromatin Remodeling

Examines SWI/SNF and ISWI complex-mediated nucleosome dynamics regulating cancer gene accessibility.

DNA Methyltransferase DNMT Inhibition

Studies DNA methyltransferase dependencies and hypomethylating agent responses in epigenetically silenced cancer.

Ten-Eleven Translocation TET Enzyme Function

Investigates TET-mediated 5-methylcytosine oxidation and demethylation in cancer cell differentiation.

Histone Deacetylase SIRT Sirtuin Family

Explores NAD-dependent sirtuin deacetylases regulating cancer metabolism and epigenetic state.

H3K27 Trimethylation Enhancer Bivalency

Examines polycomb-repressive complex two-mediated H3K27me3 and bivalent promoter states in cancer stem cells.

H3K4 Trimethylation Active Promoter Marks

Investigates methyltransferase SET1 and COMPASS complex-mediated active histone marks in oncogenic transcription.

H3K36 Methylation Elongation Memory Domains

Studies H3K36me3-dependent RNA polymerase II elongation and transcript fidelity in cancer.

Histone Variant H2A.Z Nucleosome Exchange

Analyzes H2A.Z incorporation and SWR1 complex function in cancer cell promoter dynamics.

Transcriptional Bursting Single-Molecule Kinetics

Investigates stochastic transcription initiation and promoter-proximal pausing regulating cancer gene expression noise.

Enhancer RNA Bidirectional Transcription

Examines enhancer-derived RNA synthesis and Mediator-dependent enhancer function in cancer.

Circular RNA Biogenesis Splicing Functions

Studies back-splicing mechanisms generating circular RNAs and their regulatory functions in cancer.

Alternative Polyadenylation 3UTR Regulation

Investigates proximal versus distal polyadenylation site usage altering mRNA stability and miRNA targeting.

RNA Binding Protein Stabilization Networks

Analyzes post-transcriptional gene expression control through mRNA-binding proteins and AU-rich element recognition.

Translation Initiation Factor eIF4E Dependency

Explores cap-dependent translation and 4EBP-mediated eIF4E sequestration in cancer protein synthesis.

Internal Ribosome Entry IRES Mechanisms

Studies cap-independent translation via IRES elements driving oncogene expression under stress.

Ribosomal Protein Mutations Cancer Ribosomopathy

Investigates ribosomal protein haploinsufficiency and selective translation in hematologic malignancies.

Protein Folding ER Stress Unfolded Protein Response

Examines endoplasmic reticulum stress sensing, ATF4/XBP1 signaling, and adaptive UPR in cancer survival.

Membrane Protein Trafficking COPII Vesicles

Studies secretory pathway transit and ER-Golgi transport of oncogenic surface receptors.

Golgi Apparatus Glycosylation Cancer Antigens

Investigates aberrant N- and O-linked glycosylation generating neo-antigens and immunogenic carbohydrate epitopes.

Sialic Acid Synthesis Immunosuppression Axis

Analyzes sialyltransferase-mediated sialylation masking cancer cell surface immunogenicity.

Glycolipid Metabolism Sphingolipid Signaling

Studies ceramide synthase and sphingosine-1-phosphate signaling regulating cancer cell survival.

Exosome Biogenesis ESCRT Sorting Machinery

Investigates endosomal sorting complex required for transport machinery packaging tumor antigens into exosomes.

Tetraspanin CD9 CD63 Exosome Cargo

Examines tetraspanin-mediated exosome biogenesis and selective cargo loading in cancer intercellular communication.

Intercellular Tunneling Nanotube Transfer

Studies actin-based membrane bridges enabling direct transfer of mitochondria and organelles between cancer cells.

Mechanical Stiffness Mechanotransduction YAP TAZ

Investigates extracellular matrix stiffness sensing and Hippo pathway-independent YAP/TAZ activation in cancer.

Integrin Signaling Focal Adhesion Dynamics

Explores αvβ3 integrin-mediated mechanotransduction and focal adhesion kinase phosphorylation driving migration.

Cancer-Associated Fibroblast Secretome Proteomics

Analyzes CAF-derived growth factors and extracellular matrix proteins remodeling tumor microenvironment.

Ferroptosis Iron-Dependent Cell Death Mechanisms

Investigation of regulated cell death pathways dependent on iron metabolism and lipid peroxidation as therapeutic targets in cancer.

Immunometabolism Tumor-Associated Immune Cell Reprogramming

Study of metabolic rewiring in anti-tumor immune cells to enhance effector functions and overcome immunosuppressive microenvironment constraints.

Tumor Mutational Burden Neoantigen Load Prediction

Development of computational and experimental methods to identify and validate immunogenic neoantigens arising from somatic cancer mutations.

PTEN Loss Hyperactivated PI3K Signaling Addiction

Mechanistic analysis of phosphatase and tensin homolog loss consequences and therapeutic vulnerabilities in PI3K-driven cancers.

Achilles Heel Tumor Synthetic Lethal Interaction Discovery

High-throughput screening and validation of genetic interactions that selectively kill cancer cells while sparing normal tissues.

Tumor Initiating Cell Plasticity Differentiation Heterogeneity

Characterization of dynamic transitions between cancer stem cell states and differentiated populations affecting therapeutic resistance.

Stroma-Tumor Cross-Talk Paracrine Signaling Dependencies

Analysis of bidirectional secreted factor communication between malignant cells and stromal components supporting tumor progression.

Translational Control mRNA Stability Cancer Proliferation

Examination of post-transcriptional regulatory mechanisms controlling oncogene expression and therapeutic response in cancers.

Protein Aggregation Amyloid Formation Cancer Pathogenesis

Investigation of aberrant protein misfolding and aggregate accumulation in cancer biology and as druggable vulnerabilities.

Lymphangiogenesis Tumor Lymph Node Metastasis Promotion

Study of lymphatic vessel formation in tumors and lymph node microenvironment remodeling facilitating regional dissemination.

Circulating Tumor Cell Heterogeneity Hematologic Dissemination

Comprehensive analysis of circulating tumor cell diversity, epithelial-mesenchymal spectrum, and metastatic seeding capacity.

Immune Exclusion Fibrotic Barrier Immunotherapy Penetration

Mechanisms of desmoplastic stroma-mediated immune cell exclusion and therapeutic strategies to enhance immunotherapy efficacy.

Phospholipid Remodeling Membrane Composition Cancer Signaling

Role of altered membrane lipid composition in cancer cell signaling, metastatic capacity, and therapeutic resistance.

Enhancer Hijacking Super-Enhancer Oncogenic Activation Mechanisms

Characterization of aberrant transcriptional enhancer architecture driving oncogene overexpression in distinct cancer types.

Mitochondrial Dysfunction Oxidative Phosphorylation Cancer Metabolism

Investigation of mitochondrial mutations and metabolic reprogramming enabling selective energy production in malignant cells.

Tumor Exosome Immunosuppressive Cargo Systemic Effects

Analysis of small extracellular vesicle-mediated delivery of immunosuppressive molecules and organotropic metastatic priming.

Nuclear Envelope Rupture Genomic Instability Induction

Mechanisms of nuclear lamina disruption and resulting chromosomal damage contributing to cancer progression.

Glycosylation Pattern Immunoescape Carbohydrate Antigen Masking

Role of aberrant protein glycosylation in immune recognition evasion and therapeutic targeting strategies.

Lipid Droplet Accumulation Tumor Energy Storage Survival

Functions of lipid-storing organelles in cancer cell survival, drug resistance, and metabolic adaptation mechanisms.

Autophagy Flux Nutrient Scarcity Stress Response Adaptation

Investigation of selective autophagy pathways sustaining cancer cell survival under nutrient-deprived microenvironmental conditions.

Ubiquitin Signaling Code Substrate Recognition Cancer Biology

Delineation of ubiquitin chain topology and linkage-specific signaling mechanisms driving cancer phenotypes.

Telomerase Reactivation Alternative Lengthening Immortalization Pathways

Molecular mechanisms underlying telomere maintenance pathway selection in malignant cells and therapeutic intervention strategies.

Histone Variant Incorporation Chromatin Remodeling Cancer Epigenetics

Functions of non-canonical histone proteins in altered chromatin structure and gene expression patterns in tumors.

Nutrient Competition Tumor Stroma Glucose Amino Acid Scarcity

Spatial dynamics of nutrient availability between malignant and stromal cells shaping tumor microenvironment fitness.

Thrombosis Platelet Aggregation Tumor Cell Vascular Adhesion

Mechanisms of tumor cell-induced coagulation activation facilitating hematogenous dissemination and immune evasion.

Soluble Factor Secretion Tumor-Systemically Acting Cytokines

Investigation of cancer-derived circulating factors inducing systemic inflammation and pre-metastatic niche preparation.

Chromatin Accessibility Transcription Factor Occupancy ATAC-seq

High-resolution mapping of open chromatin regions and transcription factor binding landscape in cancer genomes.

Stress Granule Formation Translational Reprogramming Drug Stress

Role of cytoplasmic stress granules in cellular response to chemotherapy and kinase inhibitor-induced proteotoxic stress.

RNA Editing ADAR Enzymes Adenosine-to-Inosine Conversion Cancer

Mechanisms of RNA editing enzyme dysregulation altering cancer-related transcript sequences and protein functions.

Tumor Acidity Lactate-Mediated Immune Suppression Microenvironment

Role of tumor-derived lactate in creating acidic hostile microenvironment suppressing anti-tumor immune cell functions.

Neurotrophin Signaling Neural-Cancer Cell Communication Perineural Invasion

Interaction between cancer cells and nerve fibers driving perineural invasion and neurologically-mediated tumor progression.

Adipokine Signaling Obesity-Driven Cancer Promotion Inflammation

Mechanisms by which altered adipose tissue-derived factors in obesity accelerate cancer development and metastasis.

SUMO Modification Transcriptional Regulation Cancer Stress Response

Role of small ubiquitin-like modifier conjugation in cancer cell adaptation to therapeutic and environmental stresses.

Membrane Curvature BAR Domain Proteins Endocytic Trafficking Cancer

Functions of membrane-remodeling proteins in altered endocytic pathways supporting cancer cell survival and metastasis.

Integrins Focal Adhesion Kinase Mechanotransduction Metastasis Initiation

Mechanotransduction signaling through integrin-mediated adhesion complexes enabling cancer cell migration and extravasation.

Semaphorin Signaling Axon Guidance Molecules Cancer Cell Migration

Aberrant expression of neuronal guidance molecules promoting directional migration and metastatic dissemination of cancer.

Tumor Stiffness Collagen Deposition Matrix Mechanotransduction

Role of altered extracellular matrix composition and mechanical properties in tumor progression and therapy resistance.

Fibroblast Growth Factor Signaling FGF Receptor Dependencies

Mechanisms of aberrant FGF-FGFR signaling promoting growth factor-driven cancer malignancy and drug resistance.

Notch Signaling Stem Cell Maintenance Differentiation Balance

Role of Notch pathway in controlling cancer stem cell self-renewal versus differentiation and therapeutic vulnerability.

Hedgehog Signaling Paracrine Tumor-Stromal Crosstalk

Functions of aberrant Hedgehog pathway activation in tumor-fibroblast communication supporting desmoplasia and progression.

TGF-Beta Signaling Epithelial-Mesenchymal Transition Immunosuppression

Multifunctional role of transforming growth factor-beta in promoting EMT, fibrosis, and immune cell dysfunction.

Myc Addiction Transcriptional Dependencies Synthetic Lethal Strategies

Investigation of oncogenic MYC overexpression dependencies and identification of selective therapeutic targets in MYC-driven cancers.

Nuclear Factor-Kappa B Inflammation-Driven Cancer Progression

Mechanisms of NF-kappaB pathway dysregulation promoting inflammatory microenvironment and malignant transformation.

Signal Transducer Activator Transcription STAT3 Signaling Cancer

Role of constitutive STAT3 activation in cancer cell proliferation, invasion, and immunosuppression mechanisms.

Wnt-Beta Catenin Nuclear Accumulation Transcriptional Reprogramming

Characterization of dysregulated Wnt signaling effectors and resulting transcriptional changes driving cancer stemness.

Drug Efflux Transporter ABC-ATPase Multidrug Resistance Mechanisms

Investigation of ATP-dependent drug pump overexpression and therapeutic strategies to overcome active drug extrusion.

Target Sequestration Subcellular Compartmentalization Drug Inaccessibility

Mechanisms of therapeutic target sequestration in membrane-bound compartments preventing drug engagement and efficacy.

Aneuploidy Tolerance Chromosomal Instability Evolutionary Adaptation

Investigation of cellular mechanisms allowing survival with massive chromosome number imbalances and selection of viable aneuploid clones.

Chromothripsis Complex Rearrangement Chromosome Shattering Reassembly

Mechanisms and consequences of catastrophic chromosome shattering and random reassembly generating oncogenic rearrangements.

Fusion Oncogene Products Breakpoint Characterization Structural Variants

Identification and functional characterization of cancer-driving chimeric proteins arising from chromosomal translocations.

Pyroptosis Inflammasome Activation Immunogenic Death

Study of pyroptotic cell death triggered by inflammasome activation in cancer cells to enhance anti-tumor immune responses.

Autophagy-Dependent Cancer Cell Survival Mechanisms

Analysis of how cancer cells exploit autophagy pathways to survive therapeutic stress and targeting strategies to overcome resistance.

Metabolic Addiction Glucose Glutamine Dependencies

Characterization of cancer cell metabolic vulnerabilities and amino acid addiction states for targeted metabolic intervention.

One-Carbon Metabolism Folate Cycle Dependency

Study of one-carbon metabolism and folate cycle dependencies in rapidly dividing cancer cells for therapeutic targeting.

Nucleotide Biosynthesis Cancer Proliferation Requirements

Analysis of de novo nucleotide synthesis pathways and their essential role in supporting high cancer cell proliferation rates.

Mitochondrial Dysfunction ROS Stress Response

Examination of reactive oxygen species production and mitochondrial stress responses as drivers of cancer cell adaptation and therapy resistance.

Cancer Cell Plasticity Differentiation State Switching

Investigation of phenotypic switching and dedifferentiation mechanisms enabling cancer cells to adopt multiple cellular identities.

Tumor Intrinsic Angiogenesis Alternative Vessel Formation

Study of vasculogenic mimicry and non-angiogenic blood supply mechanisms in tumors resistant to anti-angiogenic therapy.

Cancer-Associated Adipocytes Lipid Exchange

Analysis of lipid transfer between cancer-associated adipocytes and tumor cells supporting metabolic adaptation and drug resistance.

Tumor Ecosystem Nutrient Competition Scavenging

Investigation of nutrient competition dynamics within tumors and mechanisms by which cancer cells scavenge limited resources.

Protein Synthesis mTORC1 Translation Control

Study of translational control mechanisms and mTORC1-dependent protein synthesis as vulnerability in cancer cells.

Unfolded Protein Response ER Stress Cancer

Characterization of endoplasmic reticulum stress response pathways in cancer cells as targets for therapeutic intervention.

Proteasome Inhibitor Resistance Adaptive Mechanisms

Analysis of compensatory proteolytic pathways and adaptive responses enabling cancer cell survival after proteasome inhibition.

Cancer Cell Senescence Escape Immortalization

Investigation of telomerase reactivation and senescence bypass mechanisms during malignant transformation and immortalization.

Chromothripsis Catastrophic Chromosome Rearrangement

Study of chromothripsis and other massive chromosomal rearrangements as oncogenic drivers in specific cancer types.

Circular DNA Extrachromosomal Amplifications Oncogenes

Investigation of extrachromosomal DNA circles and episomes amplifying oncogenes and driving heterogeneous cancer populations.

Transposable Element Reactivation Cancer Mutagenesis

Examination of transposable element activation in cancer cells causing insertional mutagenesis and genomic instability.

Fusion Gene Oncogenes Recurrent Translocations

Analysis of recurrent chromosomal translocations generating fusion proteins with altered function and cancer vulnerability.

Homologous Recombination Deficiency Synthetic Lethality

Study of BRCA-mutant cancers and homologous recombination deficiency as substrate for PARP inhibitor and platinum sensitivity.

Mismatch Repair Deficiency Mutation Burden

Investigation of mismatch repair loss creating hypermutant cancers with elevated neoantigen load and immunotherapy responsiveness.

ATRX Loss Telomere Maintenance Alternative Lengthening

Characterization of ATRX mutations and alternative lengthening of telomeres as driver events in glioma and pediatric cancers.

Chromatin Remodeling Complex SWI/SNF Mutations

Study of inactivating mutations in chromatin remodeling complexes as recurrent cancer drivers across multiple tumor types.

Histone Acetyltransferase Amplification Epigenetic Plasticity

Investigation of histone acetyltransferase amplification and enhanced chromatin accessibility in aggressive cancer phenotypes.

DNA Methyltransferase Inhibitor Immune Activation

Study of DNA methyltransferase inhibitor-mediated reactivation of silenced tumor suppressor genes and interferon responses.

Enhancer RNA Transcription Cancer Gene Regulation

Analysis of enhancer-derived RNA production and its role in super-enhancer-mediated oncogene activation in cancer.

Phase Separation Biomolecular Condensates Oncogenic

Examination of liquid-liquid phase separation and biomolecular condensate formation in cancer transcriptional regulation.

RNA Secondary Structures G-Quadruplex Stability

Investigation of G-quadruplex structures in telomeres and oncogene promoters as therapeutic stabilization targets.

Alternative Splicing Cancer-Specific Isoforms

Study of cancer-specific splicing patterns generating truncated proteins or novel peptide epitopes for targeted therapy.

RNA Editing A-to-I ADAR Dysregulation

Characterization of RNA editing dysregulation in cancer creating altered protein products with oncogenic properties.

Microenvironment pH Acidification Lactate Metabolism

Investigation of tumor acidification through lactate production and extracellular pH regulation affecting immune function.

Immune Exclusion Fibrotic Barrier Formation

Study of stromal barriers and immune-excluded tumors preventing T cell infiltration despite checkpoint blockade therapy.

Myeloid-Derived Suppressor Cell Expansion Mechanisms

Analysis of MDSC expansion and immune suppressive function in cancer microenvironment and therapy resistance.

Regulatory T Cell Infiltration Immune Tolerance

Investigation of Treg recruitment and immunosuppressive function in cold tumors and checkpoint inhibitor resistance.

B Cell Tertiary Lymphoid Structures Antibody Production

Study of B cell organization in tertiary lymphoid structures and tumor-infiltrating antibody responses in immunotherapy.

Natural Killer Cell Exhaustion Inhibitory Receptors

Characterization of NK cell dysfunction in tumors through upregulation of inhibitory receptors and metabolic constraints.

Tumor Endothelial Cell Dysfunction Barrier Integrity

Investigation of tumor vasculature endothelial cell dysfunction compromising immune cell infiltration and drug delivery.

Pericyte Coverage Vascular Maturation Resistance

Study of pericyte-endothelial interactions and vessel maturation as mechanisms of anti-angiogenic drug resistance.

Lymphangiogenesis Lymphatic Metastasis Dissemination

Analysis of lymphatic vessel formation in tumors and lymphatic-mediated metastatic spread to regional lymph nodes.

Circulating Immune Cell Exhaustion Systemic Suppression

Investigation of systemic immune dysfunction in cancer patients including peripheral T cell exhaustion and metabolic skewing.

Tumor-Associated Thrombosis Coagulation Cascade

Study of cancer-induced thrombosis through tissue factor expression and platelet aggregation supporting metastatic dissemination.

Platelet-Cancer Cell Interactions Aggregation Survival

Characterization of platelet coating protecting circulating tumor cells from mechanical stress and immunorecognition.

Exosome Protein Cargo Functional Transfer

Investigation of exosomal transfer of functional proteins including oncoproteins and immunosuppressive factors between cancer cells.

Microvesicle Phosphatidylserine Thrombotic Activity

Study of cancer cell-derived microvesicles and phosphatidylserine exposure promoting coagulation and metastatic seeding.

Apoptotic Body Engulfment Immune Education

Analysis of apoptotic body uptake by immune cells and role in tolerance versus immune priming in cancer contexts.

Vertical Transmission Metastatic Seeding Colonization

Investigation of metastatic niche preparation and extracellular vesicle-mediated vertical transmission between primary and secondary sites.

Cancer Stem Cell Quiescence Maintenance Factors

Study of molecular mechanisms maintaining cancer stem cell dormancy and signals triggering exit from quiescence.

Side Population Dye Exclusion Drug Resistance

Characterization of side population cells with enhanced drug efflux and enrichment in cancer stem cell properties.

Ferroptosis Iron-Dependent Cell Death Induction

Investigation of ferroptosis as a non-apoptotic cell death pathway triggered by iron-dependent lipid peroxidation, with applications to overcome therapy-resistant cancers and bypass apoptotic escape mechanisms.

Aldehyde Dehydrogenase Activity Stem Cell Marker

Analysis of ALDH expression as cancer stem cell marker and functional role in detoxification and metabolism.

Phase Separation Biomolecular Condensate Cancer Regulation

Study of liquid-liquid phase separation in forming membraneless biomolecular condensates that regulate oncogenic transcription factors, signal transduction hubs, and therapeutic target accessibility in malignant cells.